New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Chronic disorder occurring only in low, middle income countries prompts study to understand it at molecular level

Chronic disorder occurring only in low, middle income countries prompts study to understand it at molecular level

by Delthia Ricks , Medical XpressThe small intestine in patients with intermediate (left) and severe (right) environmental enteropathy. Credit: C. Kummerlowe, et al.,Science Translational Medici
Gastroenterology May 29,2024
Chronic disorder occurring only in low, middle income countries prompts study to understand it at molecular level

Chronic disorder occurring only in low, middle income countries prompts study to understand it at molecular level

by Delthia Ricks , Medical XpressThe small intestine in patients with intermediate (left) and severe (right) environmental enteropathy. Credit: C. Kummerlowe, et al.,Science Translational Medici
Gastroenterology May 29,2024
Two new studies evaluate agents for treating ulcerative colitis

Two new studies evaluate agents for treating ulcerative colitis

by The Mount Sinai HospitalCredit: CC0 Public DomainIn the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researc
Gastroenterology May 29,2024
Two new studies evaluate agents for treating ulcerative colitis

Two new studies evaluate agents for treating ulcerative colitis

by The Mount Sinai HospitalCredit: CC0 Public DomainIn the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researc
Gastroenterology May 29,2024
Clues to the cause of chronic gut pain

Clues to the cause of chronic gut pain

by Flinders UniversityEC cells do not modulate distension-sensitive afferents. Group data showing afferent firing to increasing distension pressures in colonic preparations from VilCrecontr
Anesthesiology & Pain May 29,2024
Clues to the cause of chronic gut pain

Clues to the cause of chronic gut pain

by Flinders UniversityEC cells do not modulate distension-sensitive afferents. Group data showing afferent firing to increasing distension pressures in colonic preparations from VilCrecontr
Anesthesiology & Pain May 29,2024
Understanding mechanisms of alcohol-associated bowel disease

Understanding mechanisms of alcohol-associated bowel disease

by First Hospital of Jilin UniversityAcetaldehyde and acetate produced by the host may impact directly or indirectly small gut bacterial overgrowth, microbial translocation and changes in the faecal m
Gastroenterology May 29,2024
Understanding mechanisms of alcohol-associated bowel disease

Understanding mechanisms of alcohol-associated bowel disease

by First Hospital of Jilin UniversityAcetaldehyde and acetate produced by the host may impact directly or indirectly small gut bacterial overgrowth, microbial translocation and changes in the faecal m
Gastroenterology May 29,2024
Using the gut-brain connection to impact brain health and disease

Using the gut-brain connection to impact brain health and disease

by Society for NeuroscienceCredit: CC0 Public DomainResearch on gut-brain communication via the immune system may help in the development of novel treatments for neurodegenerative diseases. The f
Gastroenterology May 29,2024
Using the gut-brain connection to impact brain health and disease

Using the gut-brain connection to impact brain health and disease

by Society for NeuroscienceCredit: CC0 Public DomainResearch on gut-brain communication via the immune system may help in the development of novel treatments for neurodegenerative diseases. The f
Gastroenterology May 29,2024
GI bleeding up for new users of rivaroxaban

GI bleeding up for new users of rivaroxaban

Rivaroxaban is associated with increased rates of gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants, according to a study published online Oct. 12 in theAnnals of In
Gastroenterology May 29,2024
GI bleeding up for new users of rivaroxaban

GI bleeding up for new users of rivaroxaban

Rivaroxaban is associated with increased rates of gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants, according to a study published online Oct. 12 in theAnnals of In
Gastroenterology May 29,2024
Maddening itch of liver disease comes from a surprising source

Maddening itch of liver disease comes from a surprising source

by Duke University School of NursingExcess lipids produced by liver failure signal an itching sensation directly to the skin cells, through a receptor called TRPV4 and a microRNA. Credit: Wolfgan
Hepatobiliary&Pancreas Surgery May 29,2024
Maddening itch of liver disease comes from a surprising source

Maddening itch of liver disease comes from a surprising source

by Duke University School of NursingExcess lipids produced by liver failure signal an itching sensation directly to the skin cells, through a receptor called TRPV4 and a microRNA. Credit: Wolfgan
Hepatobiliary&Pancreas Surgery May 29,2024
Chronic inflammatory bowel diseases: Predicting the success of biologicals

Chronic inflammatory bowel diseases: Predicting the success of biologicals

by Kiel UniversityThe international team led by Prof. Philip Rosenstiel and Prof. Stefan Schreiber has studied gene expression and DNA methylation in blood samples from CED patients receiving ant
Gastroenterology May 29,2024
Chronic inflammatory bowel diseases: Predicting the success of biologicals

Chronic inflammatory bowel diseases: Predicting the success of biologicals

by Kiel UniversityThe international team led by Prof. Philip Rosenstiel and Prof. Stefan Schreiber has studied gene expression and DNA methylation in blood samples from CED patients receiving ant
Gastroenterology May 29,2024
Clinically active IBD linked to adverse COVID-19 outcomes

Clinically active IBD linked to adverse COVID-19 outcomes

(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 2
Gastroenterology May 29,2024
Clinically active IBD linked to adverse COVID-19 outcomes

Clinically active IBD linked to adverse COVID-19 outcomes

(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 2
Gastroenterology May 29,2024
Two-organ chip developed to answer fatty liver questions

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya
Hepatobiliary&Pancreas Surgery May 29,2024
Two-organ chip developed to answer fatty liver questions

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya
Hepatobiliary&Pancreas Surgery May 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com